Chapter 56: Giving out red envelopes
As an innovative drug that has just been launched, both doctors and patients are still exploring "ITG human myelopoietin".
As patients continue to receive "ITG" injection treatments in the next few days, the complete treatment plan and cost of the first version of "ITG Generator" have been summarized.
For patients with common aplastic anemia, it is first recommended to undergo eight weeks of treatment with a total of eight injections;
After the eighth week, a full set of routine blood tests and blood cell smearing are performed. If all the blood pictures are normal, then a bone puncture can be performed directly to confirm whether it is cured.
If the blood picture is still abnormal, two more injections will be given, and bone puncture will be performed after ten injections.
The final cost of this set of treatment is no more than 30,000 yuan. If you are lucky, eight injections will only cost you 25,000 yuan!
For patients with super-severe aplastic anemia, they are also injected with twelve injections and then undergo routine blood tests. If there are no problems, bone marrow puncture is performed.
The cost of this set is not high, plus the examination fees, diagnosis and treatment fees, it comes to 35,000 yuan!
However.
This set of plans is only a plan package of Chengcheng Third People's Hospital. Hospitals such as Huaxi and Ruijin also have different plans and prices.
So in the past few days, aplastic patients have been sharing treatment plans from well-known hospitals across the country, comparing prices, etc. in patient groups, forums and other places...
In the end,
Rongcheng Third People's Hospital has become the first choice for the vast majority of patients with aplastic anemia due to its rich experience and reputation. Many patients from other places even fly thousands of miles to be hospitalized!
For a time, the Third People's Hospital of Chengdu admitted the largest number of patients with aplastic anemia, and the department's influence increased dramatically.
Dean Zhou was so happy that he opened his mouth from ear to ear. Faced with the surge in the number of outpatients and inpatients, he hurriedly added two more outpatient doctors in the outpatient center, and also urgently added a dozen beds in the inpatient department.
Of course,
As we all know, the Department of Hematology is not just about "aplastic anemia",
Looking at the laughter and joy of the aplastic patients in the outpatient clinic, Patients suffering from leukemia and Henoch-Schonlein purpura cannot express their feelings after receiving treatment.
Are you jealous? A little bit.
Are you talking about envy? That's for sure.
You know, more than a year ago, all patients with aplastic anemia still needed long-term blood and plate transfusions like them, and they also needed to take medicine for the rest of their lives, but what about now?
Qingshan Pharmaceutical saved them.
Thinking about it, all blood patients couldn’t help but feel extremely sad.
“Patients with aplastic anemia can be saved by Qingshan Pharmaceutical, but who will save themselves?”
"Is it still Qingshan Pharmaceutical?"
......
No one can hear their inner cry. On the other side, with the successful launch of "ITG Human Myelopoietin", the first batch The sales amount is also calculated.
This time, "ITG Generator" has received purchase orders from the top 30 hematology hospitals in the country before it is officially sold. In addition, the unit price of "ITG" is much higher than that of "Qingshan Ava".
The amount of liquidity on Qingshan Pharmaceutical’s accounts now is terrifying!
"Zhang Yang, a total of 32 hospitals purchased our 'ITG Generator' in the first batch, and a total of 30,000 injections were sold, with a sales amount of 84 million yuan!" After paying 50% of the fee, but adding in the previous working capital, our current working capital has reached 87 million yuan!”
87 million!
Zhang Yang finally smiled and felt much more relaxed.
The important thing is not making so much money, but that Qingshan Pharmaceutical finally has stable, sustained and profitable income!
Next, the annual profits generated by "Qingshan Afa" and "ITG" will be enough to support the development of Qingshan Pharmaceutical for a long time!
However,
While excited, he quickly thought of something, and then picked up the phone and called the financial director in charge of finance - Lao Qian, Qian Tu.
Qian Tu is in his forties. He was an employee recruited when Qingshan Pharmaceutical was first established. He previously worked in a private enterprise and has quite a lot of work experience.
After receiving a call from Zhang Yang, Qian Tu did not dare to neglect and hurried over with a pile of financial report documents in his hand. "Mr. Zhang, what aspect of my financial situation do you want to ask me? Is it sales profit or current account revenue?"
Zhang Yang was stunned for a moment, then smiled and shook his head:
"No, I called you here today because I am going to send a red envelope to everyone in the company!"
" Red envelope?" Qian Tu was also stunned.
“That’s right.”
Zhang Yang nodded:
"The successful launch of the company's 'ITG Generator' can be considered a good start."
"Everyone has been busy working on this matter for a long time in the past six months, and sending a red envelope is considered a project reward. Right."
"It's not much. All drug developers will get a bonus of 30,000 yuan, and other internal staff will get a bonus of 20,000 yuan, including you."
Qian Tu suddenly became excited. Get up,
He could understand the drug developers receiving bonuses, but he didn’t expect that the back-office staff would also receive bonuses!
"Thank you, Mr. Zhang, thank you, Mr. Zhang..."
Zhang Yang waved his hand and looked at Ren Xiaomin:
"By the way, Brother Ren, I think the company now We should also build a staff canteen.”
“We will have more and more employees in the future. It is not good for everyone to eat too much takeout every day. It is better for the company to pay for a staff canteen and serve breakfast every day. Three meals a day..."
"Also, the company should be equipped with two cars. You can drive wherever you go to do business, which is more convenient..."
Ren Xiaomin was slightly startled, then nodded:
"I agree."
"Now that we have barely developed, we should also get these employee benefits!"
……
While Zhang Yang was improving employee benefits, on the other side, Renaissance Pharmaceuticals, which had previously cooperated with AkaRx, was holding a high-level high-level meeting.
"Mr. Guo, I have heard some thoughts within the AkaRx company. They may lower the price again in a short period of time, from the current 3,000 yuan per box to the same price as 'Qingshan Afa', 1,599 yuan. a box . ”
“However, even if they continue to cut prices, I don’t think they can compete with Qingshan Pharmaceutical in China.”
The person who spoke was the senior executive of Fuxing Pharmaceutical who has been in contact with AkaRx. ——Gao Qiang.
Sitting in the middle of the conference room was Guo Yue, the president and CEO of Fuxing Pharmaceutical.
After hearing Gao Qiang's words, the senior management present fell silent, and even President Guo Yue couldn't help but frown.
Everyone knows that Gao Qiang is telling the truth.
A drug can still gain sales by relying on connections even if its price is similar and its efficacy is similar, but now Tsingshan Pharmaceutical not only has "Qingshan Ava", but also has an exclusive drug - "ITG" Human Myelopoietin”.
Under such circumstances, which hospital dares not to purchase Qingshan Ava?
After about ten seconds, the silence in the conference room was broken. A senior executive sitting in the middle frowned:
"Then what should we do next?"
"Are we just watching AkaRx being beaten down and our profits disappearing?"
"We should find a way to recover now. The situation!”
……
(End of this chapter)